All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

7

Part D and Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 7 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Cosentyx Sensoready (2 Pens)

Secukinumab

D$818M-4%14,195$57,596$3,543.08
Cosentyx Unoready Pen

Secukinumab

D$378M+1866%6,469$58,411$3,705.60
Cosentyx Sensoready Pen

Secukinumab

D$248M+21%4,582$54,188$7,269.28
Cosentyx (2 Syringes)

Secukinumab

D$83.5M+0%1,642$50,871$3,594.22
Cosentyx

Secukinumab · J3247

B$54.2Mn/a3,236$16,757$17.24
Cosentyx Syringe

Secukinumab

D$34.2M+21%696$49,113$7,268.77
Cosentyx

Secukinumab

D$1.1Mn/a60$18,892$418.27

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.